These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 3496045
1. Comparative toxicity and antioxidant activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B-generated metabolites in isolated hepatocytes and liver microsomes. Ekström G, Di Monte D, Sandy MS, Smith MT. Arch Biochem Biophys; 1987 May 15; 255(1):14-8. PubMed ID: 3496045 [Abstract] [Full Text] [Related]
2. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Di Monte D, Ekström G, Shinka T, Smith MT, Trevor AJ, Castagnoli N. Chem Biol Interact; 1987 May 15; 62(2):105-16. PubMed ID: 3496169 [Abstract] [Full Text] [Related]
3. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites. Cashman JR. Toxicology; 1987 Feb 15; 43(2):173-82. PubMed ID: 2949395 [Abstract] [Full Text] [Related]
4. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+. Wu E, Shinka T, Caldera-Munoz P, Yoshizumi H, Trevor A, Castagnoli N. Chem Res Toxicol; 1988 Feb 15; 1(3):186-94. PubMed ID: 2979730 [Abstract] [Full Text] [Related]
5. MPTP and MPTP analogs induced cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites. Singh Y, Swanson E, Sokoloski E, Kutty RK, Krishna G. Toxicol Appl Pharmacol; 1988 Nov 15; 96(2):347-59. PubMed ID: 3143167 [Abstract] [Full Text] [Related]
6. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC. Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685 [Abstract] [Full Text] [Related]
7. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Singer TP, Salach JI, Crabtree D. Biochem Biophys Res Commun; 1985 Mar 15; 127(2):707-12. PubMed ID: 3872126 [Abstract] [Full Text] [Related]
8. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium. Shi H, Noguchi N, Xu Y, Niki E. FEBS Lett; 1999 Nov 19; 461(3):196-200. PubMed ID: 10567696 [Abstract] [Full Text] [Related]
9. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra. Sayre LM, Arora PK, Iacofano LA, Harik SI. Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462 [Abstract] [Full Text] [Related]
10. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Kass GE, Wright JM, Nicotera P, Orrenius S. Arch Biochem Biophys; 1988 Feb 01; 260(2):789-97. PubMed ID: 2963592 [Abstract] [Full Text] [Related]
11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes. Di Monte D, Jewell SA, Ekström G, Sandy MS, Smith MT. Biochem Biophys Res Commun; 1986 May 29; 137(1):310-5. PubMed ID: 3487319 [Abstract] [Full Text] [Related]
12. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes. Di Monte D, Sandy MS, Blank L, Smith MT. Biochem Biophys Res Commun; 1988 Jun 16; 153(2):734-40. PubMed ID: 3260098 [Abstract] [Full Text] [Related]
13. MPTP, MPP+ and mitochondrial function. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE. Life Sci; 1987 Feb 23; 40(8):721-9. PubMed ID: 3100899 [Abstract] [Full Text] [Related]
14. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation. Hiebert CK, Sayre LM, Silverman RB. J Biol Chem; 1989 Dec 25; 264(36):21516-21. PubMed ID: 2600079 [Abstract] [Full Text] [Related]
15. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae. Trevor AJ, Castagnoli N, Caldera P, Ramsay RR, Singer TP. Life Sci; 1987 Feb 23; 40(8):713-9. PubMed ID: 3492651 [Abstract] [Full Text] [Related]
16. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes. Wu EY, Langston JW, Di Monte DA. J Pharmacol Exp Ther; 1992 Jul 23; 262(1):225-30. PubMed ID: 1625201 [Abstract] [Full Text] [Related]
17. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Singer TP, Salach JI, Castagnoli N, Trevor A. Biochem J; 1986 May 01; 235(3):785-9. PubMed ID: 3489461 [Abstract] [Full Text] [Related]
18. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Peterson LA, Caldera PS, Trevor A, Chiba K, Castagnoli N. J Med Chem; 1985 Oct 01; 28(10):1432-6. PubMed ID: 3876442 [Abstract] [Full Text] [Related]
19. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates. Ríos C, Tapia R. Neurosci Lett; 1987 Jun 26; 77(3):321-6. PubMed ID: 3497366 [Abstract] [Full Text] [Related]
20. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Castagnoli N, Chiba K, Trevor AJ. Life Sci; 1985 Jan 21; 36(3):225-30. PubMed ID: 3871243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]